Starpharma Holdings have developed a gel to treat bacterial vaginosis.
Starpharma Holdings will manufacture a gel to treat bacterial vaginosis. The product called VivaGel , due to go for trials, has an antimicrobial agent which can hinder the growth of bacteria . The gel does not cause any side-effects.
Going by the number of responses from people interested in trials, the company expects to begin product trial very soon and complete it within 8-12 weeks.
Source-Medindia